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dant activityAbstract The photophysical properties of luminescent tetra-coordinated cadmium (II) complex
formulated as [Cd(L)Cl],HL= (1-[(3-methyl-pyridine-2-ylimino)-methyl]-naphthalen-2-ol) were
synthesized and characterized by analytical and spectroscopic methods. The density function theory
calculations are used to investigate the electronic structures of the ligand and its complex. The inter-
actions of cadmium (II) complex towards bovine serum albumin (BSA) and human serum albumin
(HSA) were investigated using absorption and ﬂuorescence spectroscopic techniques at pH 7.4. The
quenching constants, binding constants and number of binding sites were determined by ﬂuores-
cence quenching method. The calculated thermodynamic parameters (DG, DH, and DS) conﬁrmed
that the binding reaction is mainly entropy-driven and hydrophobic forces played an important role
in the reaction. Here, we proposed a new synthetic procedure for the preparation of BSA and HSA
with cadmium complex nanowires. The scanning electron microscopy images show that BSA and
HSA with cadmium complex product are wire-like in structure. The complex shows enhanced
antibacterial activity compared with the free ligand and standard antibiotic chloramphenicol.
Antioxidant studies showed that the complex has signiﬁcant antioxidant activity against DPPH.
S446 M. Hazra et al.The obtained IC50 value of the DPPH activity for complex (IC50 = 138 lg/ml) showed excellent
scavenging property compared to standard ascorbic acid.
ª 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Transition metal complexes with Schiff-base ligand are impor-
tant class of compounds inmedicinal and pharmaceutical devel-
opment because wide range of their applications, including
antibacterial [1], antifungal [2] and anticancer properties [3].
Schiff bases are important intermediates in an enzymatic reac-
tions involving interaction of the amino group of an enzyme,
with a carbonyl group of the substrate. The Schiff bases have
emerged as antimicrobial agents because of their broad spec-
trum of in vitro and in vivo chemotherapeutic activity.
Among biomacro molecules, the serum albumins are the
major soluble protein constituent of the circulatory system
and also transport protein [4]. The crystal structure of human
serum albumin (HSA) revealed that the drug binding sites are
located in sub-domains IIA and IIIA [5]. Bovine serum albu-
min (BSA) is structurally homologous to HSA [6]. Human
serum albumin has one tryptophan (Trp-214) in sub-domain
IIA, whereas BSA has two tryptophan moieties (Trp-134 and
Trp-213) located in sub-domains IB and IIA, respectively.
Albumins from blood plasma can bind with pyridoxal phos-
phate, Schiff-base ligands [7], and various metal complexes
[8]. Therefore, the binding of drugs to serum albumin
in vitro, considered as a model in protein chemistry to study
the binding behaviour of proteins, research ﬁeld in chemistry,
life sciences and clinical medicine [9,10].
The design and synthesis of nanomaterials are important
for nanotechnology and nanoscience. Adsorption of protein
molecules on nanoparticles surface changes their biological
systems [11]. These bioconjugate nanoparticles are important
because of their potential applications in luminescence tagging,
imaging, medical diagnostics. Protein conjugation nanoparti-
cles have also been used as a strategy for increasing colloidal
stability [12], conferring biochemical activity [13] and enhanc-
ing biocompatibility [14].
Our interest in nitrogen–oxygen polydentate chelators are
addressed towards their potential applications [15] and we
report an account of cadmium (II) complex with formula
[Cd(L)Cl] HL= (1-[(3-methyl-pyridine-2-ylimino)-methyl]-
naphthalen-2-ol). The BSA and HSA protein binding study
of the cadmium (II) complex has been performed absorption
and ﬂuorescence spectroscopic study. The optical absorption
and ﬂuorescence emission property of the cadmium (II) com-
plex was characterized and exhibited intense ﬂuorescence emis-
sion. The antibacterial and antioxidant activity of the Schiff
base and cadmium (II) complex demonstrate that the complex
is higher activity than free ligand.
2. Experimental
2.1. Materials and physical measurements
All chemicals and reagents were obtained from commercial
sources and used as received, unless otherwise stated. Solventswere distilled from an appropriate drying agent. The elemen-
tal (C, H, N) analyses were performed on a Perkin Elmer
model 2400 elemental analyser. Cadmium analysis was carried
out by Varian atomic absorption spectrophotometer (AAS)
model-AA55B, GTA using graphite furnace. Electronic
absorption spectra were recorded on a SHIMADZU UV-
1800 spectrophotometer. The ﬂuorescence spectra of EB
bound to albumins were obtained in the Fluorimeter
(Hitachi-2000) with thermostat. IR spectra (KBr discs,
4000–400 cm1) were recorded using a Perkin–Elmer FTIR
model RX1 spectrometer. Molar conductances (M) were mea-
sured in a systronics conductivity metre 304 model using
103 mol L1 solutions in DMF solvent. Electron spray ion-
ization (ESI) mass spectra were recorded on a Qtof Micro
YA263 mass spectrometer. 1H NMR spectral data were
recorded in suitable solvent using Bruker 300, 400,
500 MHz FT-NMR spectrometer and 13C NMR was
recorded in Bruker 400 MHz spectrometer using TMS as an
internal standard in appropriate deuterated solvents. XRD
was recorded in ‘Rigaku Miniﬂex-II’ X-ray diffractometer
using CuKa radiation (k= 0.154056 nm). The stock solutions
of proteins (1.00 · 105 mol L1) were prepared by dissolving
the solid HSA and BSA in 0.05 M phosphate buffer at pH 7.4
and stored at 0–4 C in the dark. The concentrations of BSA
and HSA were determined from optical density measure-
ments, using the values of molar absorptivity of e280 = 44
720 and 35 700 M1 cm1 for BSA and HSA, respectively.
Optical microscopy images were taken using an NIKON
ECLIPSE LV100POL upright microscope equipped with a
12 V–50 W halogen lamp. The samples for optical micro-
scopic study were prepared by placing a drop of colloidal
solution onto a clean glass slide. Stock solution of complex
was prepared in DMF because of the lower solubility in
water. SEM study of nanoparticles was performed using
Supra 40, Carl-ZEISS Pvt. Ltd Scanning Electron Microscope
(SEM) with an accelerating voltage of 5 kV. Samples for the
SEM study were prepared by drying a drop of the aqueous
suspension of particles on a small glass slide followed by
solvent evaporation under vacuum. To minimize sample
charging, the dried samples were coated with a thin gold layer
(<5 nm) right before SEM study.
2.2. Preparation of the ligand (HL)
The ligand HL was prepared according to the literature proce-
dure [15].
C17H14N2O: Anal. Found: C, 77.86; H, 5.34; N, 10.68;
Calc.: C, 77.12; H, 5.48; N, 10.24, m.p. 186 ± 1 C; ESI-MS:
[M+H]+, m/z, 262.16; IR (KBr, cm1): mOAH, 3448, mC‚N,
1472, mCH‚N, 1623;
1H NMR (d, ppm in CDCl3+CCl4):
15.686 (d, 1Ha); 9.976 (d, 1Hb); 8.30 (d, 1Hc); 6.89 (d, 1Hd);
8.15–7.04 (m, 9H); 2.498 (s, 1He);
13C NMR: 149.08 (C-9),
146.31 (C-1), 139.45 (C-7), 129.32–119.31 (Ar-C), 17.00 (C-
6); Yield: 90%.
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To prepare this cadmium (II) complex a common procedure
was followed as described below, using cadmium chloride
and the organic ligand (HL) in equimolar ratio (1:1). A meth-
anolic solution of HL (131 mg, 0.5 mmol) was mixed with
(100 mg, 0.5 mmol) of cadmium chloride with stirring condi-
tion and the mixture was reﬂuxed for 6 h. The orange colour
cadmium (II) complex was collected by ﬁltration and washing
with methanol and cold water and then dried in vacuo. The
pure crystallized product was obtained from methanol. Finally
the product was veriﬁed by IR, 1H NMR and mass
spectroscopy.
[Cd(L)(Cl)]: C17H13N2CdOCl: Anal. Found; C, 50.00; H,
3.18; N, 6.86; Cd, 27.45; Calc.: C, 49.84; H, 3.12; N, 6.84;
Cd, 27.42. ESI MS (m/z): M+ 408, [M+2]+ 410. IR (cm1):
mCH‚N, 1616; mCAH, 2943, mC‚N, 1469,
1H NMR (d, ppm in
DMSO-d6): 9.98 (d, 1Hb); 8.38 (s, 1Hc); 6.94 (s, 1Hd); 8.19–
7.20 (m, 9H); 2.52 (d, 1He); m.p. 219 ± 1 C; KM (DMF):
12.16 cm2 X1 M1; Yield: 80%.
2.4. Synthesis of Cd-complex with BSA/HSA nanowires
The synthesis of Cd–BSA nanowires as described below, 8 lM
BSA and 22 lM Cd(L)Cl are dissolved in 90 lL of phosphate
buffer solution of pH 7.4. The mixture as allowed to incubate
for 1 h at room temperature with continuous shaking. Incuba-
tion was followed with centrifuged at1100 rpm for about
30 min, which allows the removal of any unbound protein mol-
ecule and gives a dark orange solution of Cd–BSA nanowires
(Scheme 1). In buffer solution (pH 7.4), negative ions of BSA
molecules attached on the surface, which forms the attractive
columbic interaction between the protein and the cadmium
nanowires [16]. Similarly Cd–HSA nanowires were
synthesized.Cd-Complex with B
Nanowire 
Add HSA
PH≃7.4 
Cd-Complex
Add BSA
PH≃7.4 
Cd-Complex with HSA
Nanowire 
Scheme 1 A schematic representation for synthesi2.5. Theoretical methodology
All molecular calculations were performed in the gas phase
using Density Functional Theory (DFT) using the B3LYP
(Becke three-parameter Lee–Yang–Parr) exchange correlation
functional [17]. The basis set LanL2DZ was used to cadmium
(II) complex for all atoms. All calculations were carried out
using the GAUSSIAN 09 program package with the aid of
the Gauss View visualization program [18,19].
2.6. Protein (BSA and HSA) binding experiments
The quantitative analyses of the interaction between Cd (II)
complex and serum albumins were performed by absorption
spectra and ﬂuorimetric titration in presence of phosphate buf-
fer at pH 7.4. A 3.0 mL portion of aqueous solution of protein
was titrated by addition of the appropriate concentration of
Cd (II) complex solution (to give a ﬁnal concentration of
4.5 · 106 mol L1). For every addition, the mixture solution
was shaken and allowed to stand for 20 min, and then the ﬂuo-
rescence intensities were measured with an excitation wave-
length of 280 nm.
2.7. Antimicrobial screening
The antibacterial activities of the ligand (HL) and its Cd (II)
complex have been studied by agar disc diffusion method
[20,21]. The antibacterial activities were done at 100 and
200 lg/mL concentrations of compound in DMF solvent by
using three pathogenic gram negative bacteria (Escherichia
coli, Vibrio cholerae, Streptococcus pneumoniae) and one gram
positive pathogenic bacteria (Bacillus cereus). The solution of
ligand and its Cd (II) complex was added to the agar plates.
The DMF solvent was used as a negative control. Incubation
of the plates was done at 37 C for 24 h, inhibition of theSA
Green Fluorescence 
Yellowish Green Fluorescence 
Excited by 
UV light
Excited by 
UV light
s of Cd-complex with BSA or HSA nanowires.
Figure 1 Powder XRD pattern of cadmium (II) complex.
S448 M. Hazra et al.organisms was measured and used to calculate mean of inhibi-
tion zones in millimetres.
2.8. DPPH radical scavenging activity
The free radical scavenging activity of the ligand and Cd (II)
complex was determined by using 1,1-diphenyl-2-pic-
rylhydrazyl (DPPH) free radical scavenging method. The com-
pound was dissolved in hot methanol (20 mg/20 ml) and used
as stock solution. From the stock solution, 1 mL of different
concentrations (50–500 lg/mL) of sample in methanol were
added to 4 mL of a 1.42 · 105 M DPPH solution and mixed,
and then solution was left to stand at room temperature in the
dark. After 30 min of incubation, the absorbance of the solu-
tion was measured at 520 nm using UV–Vis spectrophotome-
ter [22,23]. Ascorbic acid used as standard, DPPH solution
was used as control with-out the test compounds and methanol
was used as blank. The percentage of scavenging activity of
DPPH free radical was measured by using the following
formula:
% of scavenging activity ¼ ½Ac  At
Ac
 100
where Ac is the absorbance of the control and At is the absor-
bance of sample. The scavenging activity was expressed as IC50
value which is deﬁned as the concentration (lg/ml) of com-
pound required for scavenging of DPPH radicals by 50%.
3. Results and discussion
3.1. Synthesis and characterization
The organic ligand (HL= (1-[(3-methyl-pyridine-2-ylimino)-
methyl]-naphthalen-2-ol) was synthesized by the reaction of
the respective of 3-methyl-2-amino pyridine (5.0 mmol) and
then 5.0 mmol of 2-hydroxy-1-naphthaldehyde in presence of
Ethanol. The complex was obtained in good yield from the
equimolar reaction of the cadmium (II) chloride and HL in
the methanol medium. The complex conductivity measurement
in DMF solution results that the molar conductivity values of
12.16 cm2 X1 M1 suggest that complex exist in solution as a
non-electrolyte. The complex is monomeric, non-hygroscopic,
orange coloured solids, partly soluble in ethanol, methanol,
and soluble in DMSO and DMF solvent. From Satisfactory
analytical results such as conductivity, UV–Vis spectra and
magnetic moment measurement (l= 0.0 B.M) indicate com-
plex is distorted tetrahedral geometry.
3.2. Infrared, NMR, mass spectra and electronic spectral studies
The IR spectra provide valuable information regarding the nat-
ure of functional group attached to the metal atom. Infrared
spectral data of the Schiff base showed several bands at 1472
and 1623 cm1 due to PyridineC‚Nand imineCH‚Nstretch-
ing vibrations in the solid state and a broad band in the region
3200–3432 cm1 which attributed to the intramolecular hydro-
gen bonding. The hydroxyl hydrogen of ligand is replaced by a
metal in complex and bands are shifted to lower frequency on
complexation with cadmium (II) ion. New vibrations at 412
and 518 cm1 which are not present in the free Schiff base are
attributed to the existence of (Cd–O) and (Cd–N).The 1H NMR spectra of the cadmium (II) complex have
been recorded in DMSO-d6 (Fig. S1). The complex exhibits
methyl proton (He) appeared at d 2.52 ppm, aromatic pyridine
proton (Hb) appeared at d 9.98 ppm, Hc appeared at d
8.38 ppm, Hd appeared at d 6.94 ppm, aromatic and heteroar-
omatic proton signals at d 8.19–7.20 ppm and DMSO-d6
appeared at d 3.45 ppm. Moreover, the weakening of the signal
(Ha) at d of ca. 15.68 attributable to –N–H. . .O proton in the
spectra of the free Schiff base ligand; this signal is absent in the
spectrum of its cadmium (II) complex. The result indicated
that the Schiff base is coordinated to the metal ion in the enolic
form by deprotonation. In the cadmium (II) complex, the aro-
matic and heteroaromatic proton signals appeared downﬁeld,
due to increased conjugation on coordination.
13C NMR spectra of the complex (Fig. S2) and ligand
showed analogous character. In a complex the hydroxyl car-
bon (C-1) was found at 150.04 ppm, pyridine carbon (C-2) at
147.74 ppm, imine carbon (C-3) at 141.35 ppm, and the methyl
carbon (C-4) signal was found at 17.62 ppm and aromatic car-
bons at 120.5–130.6 ppm. The mass spectrum of the cadmium
(II) complex also supports its projected formulation. The mass
spectrum of complex was recorded (Fig. S3) and its indicates
that the molecular ion peak m/z at 262.16, consistent with
the molecular weight of the ligand, whereas its cadmium (II)
complex shows the molecular ion peak at m/z 408.86, 262.16,
155, 107, 93 which conﬁrms the stoichiometry of the cadmium
(II) complex to be [Cd(L)Cl]. A weak peak at m/z 410.82 cor-
responds to [M+2]+ peak possibly due to the presence of iso-
topic chlorine in the cadmium (II) complex.
The electronic spectrum of cadmium (II) complex was
recorded in DMF at room temperature. All the spectra of com-
plex shows lower bands than 400 nm are due to pﬁp* and
nﬁp* transitions for the aromatic ring. An intense band at
255 nm is assigned to pﬁp* transition along with the weak
band at around 317 nm is due to a charge transfer d(Cd)ﬁp*
transition (MLCT).
3.3. Powder diffraction studies
The X-ray powder pattern of cadmium (II) complex show-
ing prominent peaks has been shown in Fig. 1. All the
Synthesis of biologically active cadmium (II) complex S449prominent peaks of the different scale particles represent its
crystalline nature. The powder patterns of different scale
particles are well concurrent with each other and it indi-
cates that different forms of complexes have the same
structure and no impurities are detected from the XRD
patterns [24].
3.4. Electronic structure
Full geometry optimization of HL and cadmium complex
was carried out using density functional theory (DFT) at
the B3LYP level in their ground state and the frontier orbi-
tals of HOMO and LUMO of HL and complex are given in
Fig. 2. From density functional theory (DFT) HL is not a
planar structure, there occurs a conjugation between hydro-
xyl hydrogen and imine nitrogen atom. The selected bond
distances and bond angles are reported in Table S1. Thus,
it is apparent that HOMO of HL, the electrons are localized
on pyridine and naphthalene ring but in complex electrons
are largely localized in Cl-atom and imine group. In LUMO,
electrons are largely localized on naphthalene ring. The
HOMO–LUMO energy gap in the ground state of complex
has been predicted to be 0.0336 eV and is not inﬂuenced on
excitation. The N1AC1AN2 bond angle of HL is 119.30
but on complex formation the bond angle decreases about
99.90. This indicate the organic moiety strongly bind to
cadmium (II) ion. All the bond angles and bond length indi-
cate the cadmium (II) complex is a distorted tetrahedral
geometry.HOMO 
E= -1.0 eV E
LUMO
        E = 0.0 eV E =
Optimized 
Structure
HL
N1
N2
O1C1C2
C3
C4 C5
C6
C7
C8
C9
C10 C11
C12
C13
C14
C15C16
C17
Figure 2 The HOMO, LUMO orbital’s and optimized structures o3.5. Proteins (BSA and HSA) binding experiments
3.5.1. Absorption characteristics of BSA and HSA–Cd (II)
complex
A pure BSA and HSA have a strong absorption band at
280 nm originating from the aromatic tryptophan and tyrosine
residues. The absorption spectra of BSA and HSA in the
absence and presence of Cd (II) complex was studied at differ-
ent concentrations. From this study we observed that absorp-
tion of BSA and HSA increases regularly upon increasing the
concentration of the complex [25], indicating the formation of
a ground state complex. As dynamic quenching does not affect
the absorption spectrum of quenching molecule and it only
affects the exited states of quenching molecule, the observed
changes in serum albumins absorbance in the presence of dif-
ferent concentrations of cadmium complex could be indicative
of the occurrence of static quenching interaction between cad-
mium complex and serum albumins. The absorption spectra of
Cd (II) complex with BSA and HSA are given in Fig. 3. From
these data the apparent association constant (Kapp) determined
of the complex with BSA and HSA has been determined using
the Benesi–Hildebrand equation [26]
1=ðAobs  A0Þ ¼ 1=ðAc  A0Þ þ 1=KappðAc  A0Þ½comp
where, Aobs is the observed absorbance of the solution contain-
ing different concentrations of the complex at 280 nm, A0 and
Ac are the absorbances of BSA, HSA and the complex at
280 nm, respectively, with a concentration of complex and
Kapp represents the apparent association constant. The= -0.26195
  -0.22835
[Cd (L)Cl] complex
f HL and cadmium (II) complex obtained from DFT (B3LYP).
Figure 3 Electronic spectral titration of cadmium (II) complex with BSA (left, A) and HSA (right, B) at 280 nm in phosphate buffer.
Arrow indicates the direction of change upon the increase concentration of BSA and HSA.
S450 M. Hazra et al.enhancement of absorbance at 280 nm was due to adsorption
of the surface complex, based on the linear relationship
between 1/(Aobs  A0) vs reciprocal concentration of the com-
plex with a slope equal to 1/Kapp(Ac  A0) and an intercept
equal to 1/(Ac  A0). The value of the apparent association
constant (Kapp) of BSA and HSA determined from this plot
and the values were 3.62 · 104 M1 and 3.16 · 104 M1. All
the plots represent a good linear relationship and cadmium
(II) complex strongly adsorbed on the surface of BSA and
HSA.3.5.2. Fluorescence quenching of BSA and HSA by the cadmium
complex
The interaction of Cd (II) complex with BSA and HSA was
studying by the ﬂuorescence emission spectrum with increasing
the concentration of the cadmium complex. In presence of dif-
ferent concentrations of complex, the emission spectra of BSA
and HSA was recorded in the wavelength range 300–500 nm
by exciting the protein at 280 nm [27] and represented in
Fig. 4. The result indicate that with increasing the concentra-
tion of the cadmium complex the ﬂuorescence intensities of
the proteins are regularly decreased. The ﬂuorescence quench-
ing is described by the Stern–Volmer relation [28]
F0=F ¼ 1þ Ksv½Q ¼ 1þ Kqs0½Q
where F0 and F represent the ﬂuorescence intensities in the
absence and presence of quencher, respectively. Ksv is a linear
Stern–Volmer quenching constant, Q is the concentration ofFigure 4 Change in ﬂuorescence spectra of BSA (left, A) and HSA
phosphate buffer. The concentration of complex varied from 0.0 to 4quencher, kq is the bimolecular quenching constant, and s0 is
the average lifetime of protein in the absence of quencher,
and its value is 108 s [29]. The corresponding SternVolmer
quenching constants KSV and quenching rate constants kq
are given in Table 1.The Ksv value calculated from the plot
of F0/F versus [Q]. All the Stern–Volmer plots represent
(Fig. S4) a good linear relationship and indicating a strong
afﬁnity of the cadmium (II) complex to BSA and HSA.
Fluorescence quenching can be processed via different
mechanisms, usually classiﬁed as dynamic quenching and sta-
tic quenching. The Stern–Volmer plots represent a single
quenching mechanism; either static or dynamic [30]. The
dynamic and static quenching can be distinguished by differing
in their dependence on temperature. In dynamic quenching,
the quenching rate constant increases with increasing temper-
ature and also indicates the faster diffusion but in the case of
static quenching, the quenching rate constant decreases with
increasing temperature. The KSV increases with rising temper-
ature given in Table 1, indicating that the ﬂuorescence quench-
ing of proteins by the Cd (II) complex is a dynamic quenching
mechanism. The obtained kq values in Table 1 for the com-
pound is on the order of 1013 L mol1 s1, which is 1000-fold
higher than the maximum value possible for diffusion con-
trolled quenching (i.e., 2.0 · 1010 L mol1 s1) [31]. This obser-
vation suggests that there is a speciﬁc interaction between
serum albumins and cadmium complex. Again the Stern–Vol-
mer quenching constant KSV at different temperatures (300
and 310 K) is directly related with temperature so the probable
quenching mechanism may be dynamic rather than static.(right, B) through their titration with cadmium (II) complex in
.5 · 106 M L1; kex = 280 nm and pH 7.4.
Table 1 The quenching constants of BSA/HSA by cadmium
(II) complex.
Complex T (K) Ksv (L Mol
1) Kq (L Mol
1 S1)
Cd–BSA 300 6.94 · 104 6.94 · 1013
310 7.18 · 104 7.18 · 1013
Cd–HSA 300 4.92 · 104 4.92 · 1013
310 5.11 · 104 5.11 · 1013
Synthesis of biologically active cadmium (II) complex S451UV–Vis absorption measurements are used to study
structural changes and complex formation. For a dynamic
quenching, the absorption spectra of the substance is not
changed, and ﬂuorescence molecule is inﬂuenced by quench-
ers at the excited state, but for static quenching, a new com-
pound is formed between the ground state of the ﬂuorescent
substance and quencher therefore, the absorption spectra of
ﬂuorescence substance would be considerably inﬂuenced.
The absorption spectra of BSA and HSA in the absence
and presence of Cd (II) complex was studied at the same
concentrations (2.5 · 106 mol L1). The UV absorption
spectrum of both proteins shows a weak band with a max-
imum at 280 nm (Fig. 5). The absorption intensity of the
280 nm peaks is increased by addition of Cd (II) complex,
indicating that more aromatic acid residues were extended
into the aqueous environment. This result indicated that
the microenvironment of the three aromatic acid residues
was altered and the tertiary structure of HSA and BSA
was destroyed. These results show that the interaction
between Cd (II) complex and proteins (HSA and BSA)
was mainly a static quenching mechanism.
The calculation of KSV from Stern–Volmer plots demon-
strates that varying temperature has a moderate effect on the
ﬂuorescence quenching by Cd (II) complex. Therefore the
quenching data were analysed according to the modiﬁed
Stern–Volmer equation [32]F0
F0  F ¼
1
faKa
1
½Q þ
1
fa
where, Ka is the effective quenching constant for the accessible
ﬂuorophores, and fa is the fraction of accessible ﬂuorescence.
The plots of F0/F0  F versus 1/[Q] show a good linear rela-Figure 5 The UV–Vis absorption spectra of BSA (left, A) and HSA
Black line: the absorption spectrum of proteins. Red line: the absorptio
the same concentration, c(BSA) c(HSA) = c(cadmium (II) complex) =tionship (Fig. 6), and corresponding Ka values at different tem-
peratures are given in Table 2. The results show that the
binding constants between Cd (II) complex and proteins are
quite high. Stern–Volmer plots and modiﬁed Stern–Volmer
plots for the quenching of by Cd (II) complex at different tem-
peratures are compared. All the result indicates that Ka and
KSV’s constants increases with increasing temperature.
3.6. Analysis of binding site
Number of binding sites can be calculated from ﬂuorescence
titration data using the following equation [33]
log ½ðF0  FÞ=F ¼ log Kb þ n log ½Q
Kb and n is the binding constant and binding site of Cd (II)
complex. According to the experimental results, the linear ﬁt-
ting plots of log [(F0  F)/F] versus log[Q] can be observed
(Fig. 7). The corresponding Kb and n values, evaluated from
the slopes and intercepts of the linear plots, respectively, are
summarized in Table 3. As seen, the value of n is nearly 1
for binding of cadmium complex to the proteins used, which
indicates that proteins bind to complex 1:1 M ratio.
3.7. Thermodynamic parameters and mode of binding
In general, small molecule bound to biomacromolecule
through hydrogen bonding, Van der Waal force, electrostatic
and hydrophobic interactions. The Thermodynamic parame-
ters free energy (DG), enthalpy change (DH) and entropy
change (DS) are important for the study of binding modes.
The Thermodynamic parameters for a binding reaction can
be calculated from the following van’t Hoff equation:
ln
K2
K1
¼ 1
T1
 1
T2
 
DH
R
and DG ¼ DH TDS
where K is the equilibrium binding constant at the correspond-
ing temperature, K1 and K2 are the binding constant at
temperature T1 and T2 and R is the gas constant. The Thermo-
dynamic parameters for the system of serum albumins
cadmium complex are given in Table 2. According to Ross
and Subramanian [34] have used the sign and magnitude of
the thermodynamic parameters to decide various kinds of(right, B) in the absence and presence of cadmium (II) complex.
n spectrum of proteins in the presence of cadmium (II) complex at
2.5 · 106 mol L1.
Figure 6 Plot of F0/F0  F against [Q] in case of ﬂuorescence quenching of BSA (left, A) and HSA (right, B) through their titration with
cadmium (II) complex in phosphate buffer at 300 K (n) and 310 K ( ).
Table 2 Apparent binding constant and thermodynamic parameters for the interaction of cadmium (II) complex with BSA/HSA at
different temperatures.
Complex T (K) Ka (L Mol
1) n DH (kJ Mol1) DG (kJ Mol1) DS (J Mol1 K1)
Cd–BSA 300 1.64 · 104 1.01 36.524 24.206 202.4
310 2.17 · 104 1.04 25.734 200.8
Cd–HSA 300 1.48 · 104 1.02 32.731 23.950 188.9
310 2.26 · 104 1.02 25.839 188.93
Figure 7 Double-log plots of cadmium (II) complex quenching effect on BSA (left, A) and HSA (right, B) ﬂuorescence at 300 K (n) and
310 K ( ).
Table 3 The binding constants and the number of binding
sites of cadmium (II) compound with BSA and HSA at
different temperature.
Complex T (K) Kb (L Mol
1) n
Cd–BSA 300 4.58 · 104 0.92
310 5.62 · 104 0.92
Cd–HSA 300 1.81 · 104 0.91
310 2.25 · 104 0.92
S452 M. Hazra et al.interactions that may take place in protein association pro-
cesses. From the point of view a positive DS and DH value is
evidence for hydrophobic interactions, while those with
DH< 0 and DS< 0 by hydrogen-bonding or Van der Waals
interactions. The positive value of DH and DS indicates themajor contribution in complexation is hydrophobic interaction
and that the interaction is entropy driven process [35]. In addi-
tion to hydrophobic interaction, a possible covalent bonding
may be also considered. For a covalent bond formation DH
expected should be P120 kJ mol1, however, the value of
DH obtained here (about 36 and 32 kJ mol1 for BSA and
HSA, respectively) so it cannot expected for a covalent bond
formation. In addition, we found that these complexes remain
neutral tetra-coordinated and there is no empty position for
coordination on Cd (II) to form covalent bond with albumins.
Moreover, a larger contribution of a positive DS value, indi-
cating that the main interaction was hydrophobic contact
between complex and albumins. Hence increase the tempera-
ture hydrophobic interaction is increases, and this result indi-
cates the increasing character of binding sites therefore a
very stable complex is formed with high Kb value.
Figure 8 Optical, ﬂuorescence microscopy and SEM image of cadmium (II) complex with BSA (A-1, A-2, A-3) and HSA (B-1, B-2, B-3)
nanowires, respectively.
Synthesis of biologically active cadmium (II) complex S4533.8. SEM and ﬂuorescence microscopy study for crystallization
of Cd-complex with BSA and HSA
The intense luminescence property of cadmium (II) complex
with BSA and HSA suggests that optical and ﬂuorescence
microscopy will be a useful tool to investigate the morphology
of the nanostructures (Fig. 8). Optical micrograph of sample-A
and sample-B shows formation of wire shaped cadmium (II)
complex with BSA and HSA, respectively. Upon excitation
with blue light sample-A shows green luminescence and sam-
ple-B shows yellowish green luminescence. This suggests that
the cadmium (II) complex molecules have been incorporated
into the BSA or HSA microparticles during the solution-based
route process and they are likely to be distributed randomly. It
is supposed that during the formation of the doped
microparticles, hydrophobic and p–p interactions induce the
aggregation of BSA or HSA and cadmium (II) complex mole-
cules into wires [36].
Scanning electron microscopy (SEM) has been routinely
applied as an effective tool for the characterization of surface
morphology of cadmium (II) complex loaded BSA and HSA.The SEM images [Fig. 8(A-3 and B-3)] demonstrate that the
ﬁnal products consist of a large quantity of nanowires in both
case with a average diameter of about 102 nm and a typical
length of several tens of micrometers. These images demon-
strate the nanowires could be easily produced in large-scale
using the present method. Some nanowires grow together with
each other due to physical adsorption on the surface of the
wires.
3.9. Antibacterial activity
Antibacterial activity of the ligand and its cadmium (II) com-
plex are given in Fig. 9. Comparison the biological activity of
the synthesized ligand and its cadmium (II) compound with
standard antibiotic chloramphenicol. From the antibacterial
studies it is inferred that, complex has higher activity than
ligand. The hight of the bar represent the activity of ligand
and complexes with respect to standard chloramphenicol anti-
biotic. The increased activity of the metal chelates can be
explained by overtone concept and the Tweedy chelation the-
ory. The variation in the activity of complex against some dif-
Figure 9 Antibacterial activity of ligand and its cadmium (II) complex were done at 100 and 200 lg/mL concentrations.
Figure 10 Comparison the antioxidant activity of Ligand (HL), cadmium (II) complex and standard ascorbic acid.
S454 M. Hazra et al.ferent organisms depend either on the impermeability of the
cells of the microbes or difference in ribosome of microbial
cells [37,38]. Enhancement of activity of the compound isdue to the presence of hydroxy and methyl groups in title com-
pounds. In a complex, increases the delocalization of p-elec-
trons over the whole chelate ring and increase the lipophilic
Table 4 IC50 values of test compounds (lg/ml).
Compounds AA HL Cd-complex
IC50 value (lg/ml) 130 165 138
Synthesis of biologically active cadmium (II) complex S455
115 (2011) 20840–20848.character of the metal complex. This increased lipophilicity
also helps the penetration of the bacterial cell membranes
and blocks the metal binding sites in enzymes of microorgan-
isms and restricts further growth of the microorganisms.
3.10. Antioxidant activity
The result of free radical scavenging activity of methanolic
solutions of ligand and its compound at different concentra-
tions are shown in Fig. 10. From results it is evident that free
radical scavenging activity of the compound was concentration
dependent. The complex possessed stronger antioxidant activ-
ity than their corresponding ligand [39,40]. It can be concluded
that a less scavenging activity of ligand when compared to that
of complexes which is due to the chelation of ligand with the
central metal atom, as a result the presence of electron releas-
ing hydroxyl and electron donating methyl group in ligand
moiety able prominent improvement in radical scavenging
activity. Ascorbic acid, used as a standard, showed stronger
antioxidant activity than that of synthesized compound. The
cadmium (II) complex showed strong ability with DPPH and
expressed an IC50 value of 138.0 lg/ml lower than that of stan-
dard ascorbic acid (130.0 lg/ml), indicating they possessed
stronger antioxidant activity than corresponding ligand HL
(IC50 value of ligand is 165.0 lg/ml). The comparative antiox-
idant activity of ligand, cadmium (II) compound and ascorbic
acid as a standard is shown in Table 4.
4. Conclusions
The synthesized cadmium (II) complex was characterized by
using spectral and elemental analysis. The 1H NMR and
DFT calculation in support of the distorted tetrahedral conﬁg-
uration of cadmium (II) complex. From spectroscopic meth-
ods values Cd (II) complex strongly bind with BSA and
HSA through a static quenching mechanism. Also Stern–Vol-
mer constant indicate that the ﬂuorescence quenching proceeds
through a static process. The thermodynamic parameters (DG,
DH, and DS) suggest that hydrophobic forces played a major
role in the binding reaction and the process is endothermic.
The optical absorption and ﬂuorescence emission properties
of the nanowires were characterized and exhibited intense ﬂuo-
rescence emission. The obtained cadmium (II) complex with
BSA and HSA nanowires could be introduced as the building
block for novel optoelectronic devices. The scanning electron
microscopy images show that BSA and HSA with cadmium
complex produce wire-like in structure. The antibacterial
screening results cadmium (II) complex exhibited remarkable
antimicrobial potency. Moreover, the complex exhibited
stronger antioxidant effects than corresponding ligand and
good candidates for use in a variety of applications. The bio-
logical signiﬁcance of this work is evident since albumin serves
as an endogenous carrier for the complex in the body, which
could be a useful guide for further drug design.Acknowledgment
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